Strategy

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">Henri: N of 1</h1><h2 class="title-bottom webtitle">How the late Genzyme CEO Henri Termeer created the Orphan drug industry</h2><div class="byline">Steve Usdin, Washington Editor</div><div class="date"></div> </div></div></div>

Genzyme Corp.

Fabry's disease

Henri Termeer

Orphan drugs

Rare Diseases: From the origins of the orphan drug industry to recent efforts to expand and accelerate drug development for rare diseases. [See more analysis about rare diseases](/topics/rare-diseases).

Rare Disease Day

Henri: N of 1

Henri Termeer will be remembered as the father of the Orphan drug industry and of a pricing model that has sparked both innovation and controversy.

How the late Genzyme CEO Henri Termeer created the Orphan drug industry

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Distillery

Podcasts & Webcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

China Healthcare Summit

Bio€quity Europe

The BioCentury Show

Events

My Workspace

Company Overview

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Trial

Subscribe

Advertising & Sponsorship

Career Opportunities

Customer Resource Center

Contact

Home

<br/><br/><br/><br/><center><span style="font-size:1.25rem;font-weight:500;">Complimentary access available.  Register for a free account.</span></center><br/>

Paywall Free With Reg Title

Register for Access

<center><span style="font-weight:300;">Already have an account? [Log in]{{login}}</span></center>

Paywall Free With Reg Login